David J.A. Jenkins is a British-born University Professor in the department of Nutritional Sciences at the University of Toronto, Canada.
Jenkins is credited with developing the concept of the glycemic index as a way of explaining the way in which dietary carbohydrate impacts blood sugar. His first paper on the subject appeared in the American Journal of Clinical Nutrition in 1981. Jenkins went on to author at least 15 more clinical studies on the effects of the glycemic index. His present interests are in running clinically based dietary trials to elucidate the potential of diet to prevent and treat chronic diseases such as heart disease, cancer and diabetes.
David J.A. Jenkins has received research grants from:
Saskatchewan Pulse Growers,
the Agricultural Bioproducts Innovation Program through the Pulse Research Network,
the Advanced Foods and Material Network, Loblaw Companies Ltd.,
Unilever,
Barilla,
the Almond Board of California,
the Coca-Cola Company (investigator initiated, unrestricted grant),
Solae,
Haine Celestial,
the Sanitarium Company,
Orafti,
the International Tree Nut Council Nutrition Research and Education Foundation,
the Peanut Institute,
the Canola and Flax Councils of Canada,
the Calorie Control Council,
the CIHR,
the Canada Foundation for Innovation and the Ontario Research Fund.
He has received an honorarium from the United States Department of Agriculture to present the 2013 W.O. Atwater Memorial Lecture.
He received the 2013 Award for Excellence in Research from the International Nut and Dried Fruit Council.
He received funding and travel support from the Canadian Society of Endocrinology and Metabolism to produce mini cases for the Canadian Diabetes Association.
He has been on the speaker’s panel, served on the scientific advisory board, and/or received travel support and/or honoraria from:
the Almond Board of California,
Canadian Agriculture Policy Institute,
Loblaw Companies Ltd,
the Griffin Hospital (for the development of the NuVal scoring system),
the Coca- Cola Company,
Saskatchewan Pulse Growers,
Sanitarium Company,
Orafti,
the Almond Board of California,
the American Peanut Council,
the International Tree Nut Council Nutrition Research and Education Foundation,
the Peanut Institute,
Herbalife International,
Pacific Health Laboratories,
Nutritional Fundamental for Health,
Barilla,
Metagenics,
Bayer Consumer Care,
Unilever Canada and Netherlands,
Solae,
Kellogg,
Quaker Oats,
Procter and Gamble,
the Coca-Cola Company,
the Griffin Hospital,
Abbott Laboratories,
the Canola Council of Canada,
Dean Foods,
the California Strawberry Commission,
Haine Celestial,
PepsiCo,
the Alpro Foundation,
Pioneer Hi- Bred International,
DuPont Nutrition and Health,
Spherix Consulting and WhiteWave Foods,
the Advanced Foods and Material Network,
the Canola and Flax Councils of Canada,
the Nutritional Fundamentals for Health,
AgriCulture and Agri-Food Canada,
the Canadian Agri-Food Policy Institute,
Pulse Canada,
the Saskatchewan Pulse Growers,
the Soy Foods Association of North America,
the Nutrition Foundation of Italy (NFI),
Nutra-Source Diagnostics,
the McDougall Program,
the Toronto Knowledge Translation Group (St. Michael’s Hospital),
the Canadian College of Naturopathic Medicine,
The Hospital for Sick Children,
the Canadian Nutrition Society (CNS),
the American Society of Nutrition (ASN),
Arizona State University,
Paolo Sorbini Foundation and the Institute of Nutrition,
Metabolism and Diabetes.
